Global Weight Loss and Obesity Management Market is Predicted to be Worth US$ 170.0 Billion, Growing at a CAGR of 7.1% Over The Forecast Period (2019-2027)

Weight Loss and Obesity Management
Weight Loss and Obesity Management

Obesity is described as the accumulation of excess bodily fat. Diseases and the adoption of an unhealthy lifestyle are two key contributors to obesity around the world. Drugs, nutritional supplements, weight reduction surgery (bariatric surgery), and exercise are some of the treatments used to manage weight loss and obesity. According to the World Health Organization, a person is overweight if their BMI is larger than or equal to 25, and obese if their BMI is greater than or equal to 30.

Obesity's rising prevalence in developed and emerging economies around the world is expected to drive market growth over the estimated period. According to the World Federation of Obesity, nearly 27.4 million youngsters in India would be obese by 2030, according to reports. During the projected period, the significant rise in paediatric obesity in India is expected to drive demand for Weight Loss and Obesity Management Market strategies. Manufacturers are focused on strategic mergers, acquisitions, and collaborations to boost their market position. For example, in October 2018, Eisai Co., Ltd. agreed to grant exclusive development and marketing rights for its anti-obesity drug, lorcaserin hydrochloride, to Eurofarma Laboratories S.A. in 17 Latin American and Caribbean nations, except Brazil.

Furthermore, the Weight Loss and Obesity Management Market is predicted to rise due to increased research and development, as well as market participants' use of strategies such as collaborations and the creation of novel products to expand their global footprint. For example, Eisai Co., Ltd. and CY Biotech agreed in July 2018 to provide CY Biotech exclusive development and marketing rights in China for the anti-obesity drug lorcaserin hydrochloride (lorcaserin).

Additionally, factors such as inadequate awareness in low-income nations and the high cost of weight loss and obesity management products and services are likely to stymie market expansion throughout the projection period. Due to the rise in the obese population and rising consumption of dietary supplements across economies, "dietary supplements" will account for the largest diet segment in the Weight Loss and Obesity Management Market throughout the anticipated period.

Comments

Popular posts from this blog

Security Robot Market to Reach US$ 11.8 Billion by 2022

Intravenous Fluid Therapy is the Fastest Growing Segment Fueling the Growth of Intravenous Solutions Market

Global Report on LED Driver Market for the Forecast Period 2023-2030